Who founded Nested Therapeutics?

Nested Therapeutics was founded by Arvin Dar, Kevan Shokat, Klaus Hoeflich in 2021.

Who are Nested Therapeutics's investors?

Nested Therapeutics's investors include Versant Ventures, Foresite Capital, Sixty Degree Capital, Cowen Healthcare Investments, Goldman Sachs, Section 32.

Nested Therapeutics

Founded 2021 · 16 employees on LinkedIn · 6 known investors

Find your way into Nested Therapeutics

665 people in our graph share verified history with the Nested Therapeutics team — schools, employers, funds. One of them is your warm intro.

Dan Lynchunlockedknows Klaus Hoeflich · together at Blueprint Medicines (overlapped)

×10knows the team · via University of Toronto

knows the team · via Blueprint Medicines

Nested Therapeutics is a precision oncology company developing small-molecule cancer therapeutics by identifying overlooked driver mutations and novel binding pockets through a drug discovery platform combining genomics, computational biophysics, machine learning, and chemical biology. Its lead program, NST-628, is a brain-penetrant pan-RAF/MEK molecular glue in Phase 1 trials for MAPK-driven solid tumors, alongside a mutation-selective p53-pathway program.

AI & Machine Learning Biotech Healthtech

Founders & leadership

Nested Therapeutics was founded in 2021 by Arvin Dar, Kevan Shokat, and Klaus Hoeflich.

Arvin DarinCo-founder & Board Observer

Kevan ShokatScientific Co-founder

Klaus Hoeflich inCo-founder & former Chief Scientific OfficerCo-founder and former Chief Scientific Officer of Nested Therapeutics, a precision oncology company. Hoeflich has advanced cancer drug candidates through target discovery, IND submission, and clinical development, with experience in R&D leadership and establishing academic and industry partnerships.

Darrin MilesinChief Executive Officer

Philip KomarnitskyinChief Medical Officer

Tanja WeberinChief Business Officer

Investors · 6

Versant Ventures✓ verifiedSan Francisco · $250K – $5M

Foresite CapitalWest Hollywood

Sixty Degree CapitalNorth York

Cowen Healthcare Investmentsreported · 2 sourcesNew York

Goldman Sachsreported · 2 sourcesNew York

Section 32reportedPalo Alto

Funding

SEC filings, press & company announcements

Undisclosed amountseries AOct 2022
Source ↗

Source: company announcements and press reports — follow each round's link for the claim.

In the news

Nested Therapeutics rakes in $90 million series Acen.acs.org · Oct 2022

Nested Therapeutics raises $90M to crack new proteins in precision oncology - PharmaLivepharmalive.com · Oct 2022

Versant-founded Nested flies off with $90M series A to fund molecular glue programfiercebiotech.com · Oct 2022

Nested Therapeutics 10/6/2022 Capital Raise - Gaebler.com Venture Capital Databasegaebler.com

Frequently asked questions

What does Nested Therapeutics do?: Nested Therapeutics is a precision oncology company developing small-molecule cancer therapeutics by identifying overlooked driver mutations and novel binding pockets through a drug discovery platform combining genomics, computational biophysics, machine learning, and chemical biology. Its lead program, NST-628, is a brain-penetrant pan-RAF/MEK molecular glue in Phase 1 trials for MAPK-driven solid tumors, alongside a mutation-selective p53-pathway program.
Who founded Nested Therapeutics?: Nested Therapeutics was founded by Arvin Dar, Kevan Shokat, Klaus Hoeflich in 2021.
Who are Nested Therapeutics's investors?: Nested Therapeutics's investors include Versant Ventures, Foresite Capital, Sixty Degree Capital, Cowen Healthcare Investments, Goldman Sachs, Section 32.